We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Combination Treatment Offers Better Option for Colon Cancer Patients

By MedImaging International staff writers
Posted on 05 Jan 2022
Print article
Image: TheraSphere microscopic glass beads containing yttrium-90 (Photo courtesy of Boston Scientific)
Image: TheraSphere microscopic glass beads containing yttrium-90 (Photo courtesy of Boston Scientific)
Targeted radioembolization (TARE) alongside chemotherapy improves progress-free survival for patients with colorectal liver metastases (CLM), according to a new study.

Researchers at Northwestern University (NU; Evanston, IL, USA), the University of California, Los Angeles (UCLA; USA), and other institutions conducted an international, multicenter, open-label phase III trial of 428 patients with CLM randomly assigned to receive second-line systemic chemotherapy (with or without transarterial Yttrium-90 TARE) on a 1:1 basis. The two primary end points were progression-free survival (PFS) and hepatic PFS (hPFS), assessed by blinded independent central review.

The results showed that the patients receiving a combination of chemotherapy and TARE had longer progression-free survival, but did not improve overall survival. Some subsets of patients had greater benefit from TARE than others; characteristics which could identify patients who could benefit from addition of TARE were the location of the original colon tumor, genetic make-up of the tumor, and the amount of tumor in the liver. Importantly, the addition of TARE did not impact ability to receive subsequent therapy. The study was published on December 10, 2021, in the Journal of Clinical Oncology.

“Most patients with CLM are poor candidates for resection surgery. The cancer is either distributed in a way that it can't be operated on safely, or the size of the lesions makes it impossible,” said lead author professor Mary Mulcahy, MD, of NU. “We know systemic chemotherapy will ultimately fail, so we're looking for non-surgical therapy that can address these patients. This new treatment could be a better option compared to chemotherapy alone.”

TARE involves glass microspheres, within which a radioactive isotope (yttrium-90) is embedded. As healthy liver tissue is mainly perfused by the portal vein, TARE can be selectively administered to the tumors. The microspheres lodge in the small vessels of the tumor (embolization), emitting localized radiation therapy to targeted segments, results in tissue necrosis. The yttrium-90, with a half-life of 3.85 days, decays to Zirconium-90.

Related Links:
Northwestern University
University of California, Los Angeles



Print article
CIRS -  MIRION
Radcal

Channels

Radiography

view channel
Image: The Definium 656 HD is the company’s most advanced fixed X-ray system yet (Photo courtesy of GE Healthcare)

Next-Gen X-Ray System Brings ‘Personal Assistant’ to Radiology Departments

X-ray imaging often provides the entry point to diagnostic imaging - accounting for 60% of all imaging studies conducted. As a result, X-ray technologists, radiologists and radiology administrators are... Read more

General/Advanced Imaging

view channel
Image: uEXPLORER is the world`s first total-body PET/CT scanner (Photo courtesy of United Imaging Healthcare)

Total-Body PET Imaging Can Assess Immunological Response to COVID-19 Infections

Cytotoxic T cells are key players in the cell-mediated immune response against viral infections. However, 95% of T cells are in tissues rather than in the blood circulation and are therefore difficult... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.